Company profile: Camurus
1.1 - Company Overview
Company description
- Provider of innovative specialty medicines, with research-based development and commercialization aimed at improving treatment outcomes and quality of life for patients with serious and chronic diseases; based in Lund.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Camurus
Newcells Biotech
HQ: United Kingdom
Website
- Description: Provider of induced pluripotent stem cells (iPSCs) and their differentiated, reliable and reproducible cell and tissue types to support drug discovery, pre-clinical development, and disease mechanism investigation, including a physiologically relevant human small airway epithelial cell model that uses an air-liquid interface for research and drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newcells Biotech company profile →
Union Biometrica
HQ: United States
Website
- Description: Provider of high-throughput large-particle (10-1500 micron) flow cytometry systems for analyzing, sorting and dispensing objects too large or fragile for traditional cytometers. Products include COPAS FP, BioSorter and VISION for sorting by size, length, optical density and multiple fluorescence channels. Systems handle cells, cell clusters and small model organisms. VAST BioImager enables automated high-throughput, high-content screening and cellular-resolution imaging of zebrafish larvae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Union Biometrica company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
Sarissa Biomedical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sarissa Biomedical company profile →
Cellix
HQ: Ireland
Website
- Description: Provider of microfluidic pumping solutions, consumable biochips, software, and automated solutions for cell biology, microfluidics and nanofluidics, physics, chemistry, and cell and particle studies. Offerings include pulse-free syringe, pressure and recirculating pumps with PC control, VenaFlux for shear flow assays, the Inish Analyser for label-free cell counting, viability and transfection efficiencies, and disposable biochips for flow and droplet studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Camurus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Camurus
2.2 - Growth funds investing in similar companies to Camurus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Camurus
4.2 - Public trading comparable groups for Camurus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →